NSAIDs reign, naturals rise

via Drug Store News

Traditional OTC pain relievers remain popular, but topical and natural solutions are gaining traction.

When day-to-day life becomes a pain in the neck, consumers want fast relief. And sore necks—along with aching backs, throbbing heads and other hurting body parts—equate to big business for manufacturers of over-the-counter pain-relief medications and the retail outlets that sell them.

According to a January 2023 report from London-based Brandessence Market Research, the global OTC analgesics market was worth $26.5 billion in 2022. Moreover, the market is expected to realize a compound annual growth rate of 5.5% between 2022 and 2029.

90% of consumers desire a fast-acting formula with multiple benefits.

“The increasing geriatric population base, growing prevalence [of] chronic diseases and rising self-medication trends are creating lucrative opportunities for this industry vertical to amass notable gains,” the market research firm said.

External treatments continue to be popular within the first-aid space, too. Data from global market research firm Mintel show that 90% of consumers desire a fast-acting formula with multiple benefits, noted Jim Creagan, president of Cornwall, N.Y.-based CrossingWell Consumer Health (formerly Randob Labs).

Creagan said his company’s Sting-Kill and Chiggerex products include benzocaine for instant pain relief and also provide itch-relief benefits. The company’s Bacitraycin Plus first-aid ointment, meanwhile, not only relieves pain, but also contains bacitracin to kill germs and aloe to soothe.

Share this post

Related news

February 8, 2024

We see consumers focusing on brands they trust with flavors their children will take to bring fast-acting relief.

March 1, 2018

Privately-held Randob Labs on Thursday acquired the Balmex brand of skin protectants from Moberg Pharma as part of a $4.3 million deal.

  • Contact Us

    Whether you need retail and wholesale information, or just want to say hello, we want to hear from you.